The Solubility Studies and the Complexation Mechanism Investigations of Biologically Active Spiro[cyclopropane-1,3'-oxindoles] with β-Cyclodextrins.

Anna A Kravtsova, Anna A Skuredina, Alexander S Malyshev, Irina M Le-Deygen, Elena V Kudryashova, Ekaterina M Budynina
Author Information
  1. Anna A Kravtsova: Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
  2. Anna A Skuredina: Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia. ORCID
  3. Alexander S Malyshev: Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
  4. Irina M Le-Deygen: Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia. ORCID
  5. Elena V Kudryashova: Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia. ORCID
  6. Ekaterina M Budynina: Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.

Abstract

In this work, we first improved the aqueous solubility of biologically active spiro[cyclopropane-1,3′-oxindoles] (SCOs) via their complexation with different β-cyclodextrins (β-CDs) and proposed a possible mechanism of the complex formation. β-CDs significantly increased the water solubility of SCOs (up to fourfold). Moreover, the nature of the substituents in the β-CDs influenced the solubility of the guest molecule (MβCD > SBEβCD > HPβCD). Complexation preferably occurred via the inclusion of aromatic moieties of SCOs into the hydrophobic cavity of β-CDs by the numerous van der Waals contacts and formed stable supramolecular systems. The phase solubility technique and optical microscopy were used to determine the dissociation constants of the complexes (Kc~102 M−1) and reveal a significant decrease in the size of the formed crystals. FTIR-ATR microscopy, PXRD, and 1H-1H ROESY NMR measurements, as well as molecular modeling studies, were carried out to elucidate the host−guest interaction mechanism of the complexation. Additionally, in vitro experiments were carried out and revealed enhancements in the antibacterial activity of SCOs due to their complexation with β-CDs.

Keywords

References

  1. Chem Rev. 1998 Jul 30;98(5):2045-2076 [PMID: 11848959]
  2. J Comput Chem. 2004 Jul 15;25(9):1157-74 [PMID: 15116359]
  3. Nat Rev Drug Discov. 2004 Dec;3(12):1023-35 [PMID: 15573101]
  4. J Pharm Biomed Anal. 2016 Jan 5;117:453-63 [PMID: 26454338]
  5. Polymers (Basel). 2022 Oct 22;14(21): [PMID: 36365470]
  6. Anal Bioanal Chem. 2017 Nov;409(27):6451-6462 [PMID: 28852813]
  7. J Med Chem. 2004 Mar 25;47(7):1739-49 [PMID: 15027865]
  8. Future Med Chem. 2018 Dec;10(23):2713-2728 [PMID: 30518255]
  9. Molecules. 2021 Jul 22;26(15): [PMID: 34361579]
  10. J Pharm Pharmacol. 2016 May;68(5):544-55 [PMID: 26059798]
  11. J Pharm Biomed Anal. 2007 May 9;44(1):110-7 [PMID: 17379467]
  12. J Med Chem. 2016 Oct 13;59(19):8712-8756 [PMID: 27299736]
  13. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2109-12 [PMID: 16464578]
  14. Adv Drug Deliv Rev. 2007 Jul 30;59(7):645-66 [PMID: 17601630]
  15. Org Biomol Chem. 2016 Feb 14;14(6):2015-24 [PMID: 26754878]
  16. J Chem Theory Comput. 2019 Mar 12;15(3):1983-1995 [PMID: 30694667]
  17. J Pharm Anal. 2016 Apr;6(2):71-79 [PMID: 29403965]
  18. BMC Res Notes. 2012 Jul 23;5:367 [PMID: 22824207]
  19. J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874 [PMID: 30768902]
  20. Food Chem. 2012 Dec 1;135(3):1020-7 [PMID: 22953819]
  21. Chem Cent J. 2009 Aug 10;3:9 [PMID: 19664263]
  22. J Comput Chem. 2002 Dec;23(16):1623-41 [PMID: 12395429]
  23. Food Chem. 2016 Apr 1;196:324-30 [PMID: 26593497]
  24. Int J Pharm. 2016 Nov 30;514(1):58-72 [PMID: 27863683]
  25. Int J Pharm. 2018 Jan 15;535(1-2):272-284 [PMID: 29138045]
  26. Sci Pharm. 2018 Jan 30;86(1): [PMID: 29385698]
  27. J Pharm Biomed Anal. 2008 Jan 22;46(2):335-41 [PMID: 18055153]
  28. J Med Chem. 2019 Nov 14;62(21):9341-9356 [PMID: 31117513]
  29. Int J Pharm. 2013 Aug 30;453(1):3-11 [PMID: 23124107]
  30. J Pharm Sci. 2004 Oct;93(10):2585-94 [PMID: 15349968]
  31. Eur J Pharm Biopharm. 2010 May;75(1):33-41 [PMID: 20102737]
  32. Expert Opin Drug Discov. 2020 May;15(5):603-625 [PMID: 32106717]
  33. J Org Chem. 2018 Aug 3;83(15):8695-8709 [PMID: 29893566]

Word Cloud

Created with Highcharts 10.0.0solubilityβ-CDsSCOscomplexationviaβ-cyclodextrinsmechanism>Complexationinclusionformedmicroscopycomplexescarriedantibacterialactivityworkfirstimprovedaqueousbiologicallyactivespiro[cyclopropane-13′-oxindoles]differentproposedpossiblecomplexformationsignificantlyincreasedwaterfourfoldMoreovernaturesubstituentsinfluencedguestmoleculeMβCDSBEβCDHPβCDpreferablyoccurredaromaticmoietieshydrophobiccavitynumerousvanderWaalscontactsstablesupramolecularsystemsphasetechniqueopticaluseddeterminedissociationconstantsKc~102M−1revealsignificantdecreasesizecrystalsFTIR-ATRPXRD1H-1HROESYNMRmeasurementswellmolecularmodelingstudieselucidatehost−guestinteractionAdditionallyvitroexperimentsrevealedenhancementsdueSolubilityStudiesMechanismInvestigationsBiologicallyActiveSpiro[cyclopropane-13'-oxindoles]β-Cyclodextrinscyclopropanesspirooxindoles

Similar Articles

Cited By